Table 2 Participant characteristics at baseline
Characteristic | Participants (n = 40) |
|---|---|
Sex: female | 21 (53%) |
Race | |
White | 38 (95%) |
Black | 2 (5%) |
Ethnicity: Hispanic/Latinx | 3 (8%) |
Age (years) | |
Median (IQR) | 43.5 (28.5, 57.5) |
Mean (SD) | 43.1 (17.6) |
Medical history | |
Depression | 9 (23%) |
Anxiety | 8 (20%) |
Mood disorder (other) | 1 (3%) |
Chronic pain condition | 7 (18%) |
Previous stone history | 23 (58%) |
Prior ureteroscopy | 12 (30%) |
Prior ureteral stent placement | 13 (33%) |
Severe pain with prior ureteral stent | 8 (20%) |
Severe urinary symptoms with prior ureteral stent | 6 (15%) |
Medication use in past 30 days | |
Opioids | 11 (28%) |
NSAIDs | 20 (50%) |
Tamsulosin (or alpha blocker) | 16 (40%) |
Oxybutynin (or anticholinergic) | 3 (8%) |